CAS: 1295298-26-8
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | CCR1 antagonist 8 REF: 3D-VBC29826CAS: 1295298-26-8 | Min. 95% | A consultar | Vie 14 Jun 24 |
 | CCR1 antagonist 8 REF: TM-T14899CAS: 1295298-26-8 | - - - | A consultar | Vie 02 Ago 24 |
CCR1 antagonist 8
CAS:1295298-26-8
CAS No. 1295298-26-8 is a peptide that belongs to the class of activators with an …
Fórmula:
C22H18FN5O3S
Pureza:
Min. 95%
Peso molecular:
451.5 g/mol
Ref: 3D-VBC29826
| 1mg | A consultar | |
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar |
Entrega estimada en Estados Unidos, el Viernes 14 de Junio de 2024
CCR1 antagonist 8
CAS:1295298-26-8
CCR1 antagonist 8, a third azaindazole series compound, is a CCR1 antagonist (IC50: 1.8 nM …
Fórmula:
C22H18FN5O3S
Peso molecular:
451.47
Ref: TM-T14899
| 25mg | 1.002,00 € | |
| 50mg | 1.320,00 € | |
| 100mg | 1.994,00 € |
Entrega estimada en Estados Unidos, el Viernes 2 de Agosto de 2024
